Evidence map›Paper›PMID 29404760›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2018

Colour discrimination ellipses in choroideremia.

Immanuel P Seitz, Jasleen K Jolly, M Dominik Fischer, Matthew P Simunovic

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Choroideremia: Toward Regulatory Approval of Retinal Gene Therapy.Cold Spring Harbor perspectives in medicine · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Immanuel P SeitzUniversity Eye Hospital Tübingen, Elfriede-Aulhorn Straße 7, 72076, Tübingen, Germany.
Jasleen K JollyNuffield Laboratory of Ophthalmology, John Radcliffe Hospital West Wing, University of Oxford, Oxford, OX3 9DU, UK.
M Dominik FischerUniversity Eye Hospital Tübingen, Elfriede-Aulhorn Straße 7, 72076, Tübingen, Germany.
Matthew P SimunovicNuffield Laboratory of Ophthalmology, John Radcliffe Hospital West Wing, University of Oxford, Oxford, OX3 9DU, UK. mps23@cantab.net.
John Radcliffe Hospital · GBSTZ eyetrial · DEUniversity of Oxford · GB

Funding

Foundation Fighting Blindness CD-CL-0816-0710-SYDTistou und Charlotte Kerstan Stiftung RD-CURE WP5
6 · The paper itself

Abstract

purposeThe purpose of this study was to characterise alterations in colour discrimination in a cohort of patients with choroideremia prior to gene therapy, using a test previously validated for use in patients with retinal dystrophies.

methodsWe tested 20 eyes of 10 patients with a diagnosis of choroideremia and an age-matched cohort of 10 eyes of 10 normal controls using the "Cambridge Colour Test" (CCT), in which subjects are required to distinguish the gap in a C presented in one of 4 orientations in a Stilling-type array. Colour discrimination was probed along eight axes in the CIE L*u*v* colour space, and the resulting data were plotted in the CIE 1976 chromaticity diagram and fitted with least-squares ellipses. Subsequently, we estimated the achromatic area for each subject by calculating the area of the resultant discrimination ellipse and calculated sensitivity thresholds along relevant colour confusion axes.

resultsColour discrimination-as quantified by log

conclusionsThe majority of our patients demonstrated greater loss in tritan discrimination than in red-green colour discrimination using the CCT. There was a significant correlation between achromatic area and BCVA. In keeping with our current understanding of the machinery of colour vision, there was a significant correlation between BCVA and colour discrimination thresholds, which was stronger for red-green colour discrimination, than for tritan colour discrimination. We propose that this and similar tests of colour discrimination may prove to be suitable tools for assessing functional outcomes in gene therapy trials for choroideremia.

Indexed as

Visual AcuityAdultAgedChoroidChoroideremiaColor PerceptionColor Perception TestsColor VisionColor Vision DefectsFemaleFluorescein AngiographyFundus OculiHumansMaleMiddle AgedRetinal Pigment EpitheliumChoroideremiaColour discriminationColour visionColour vision deficiency

Identifiers

PMID29404760
OpenAlexW2786788870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.